Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Jaguarhealth.gcs-web.com save search
Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference
Published: 2023-09-14 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 3.17%
H: 1.51%
C: -5.23%
conference health presentation global
Patent Issued in Japan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Published: 2023-09-13 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: -0.74%
H: 3.71%
C: -6.39%
patent japan health treatment
Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
Published: 2023-09-12 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 2.73%
H: 0.0%
C: 0.0%
np-300 drug candidate institute diarrhea health application family funding
Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference
Published: 2023-09-11 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -2.94%
conference health presentation growth
Jaguar Health's Executive VP Dr. Karen Brunke Joins BIO's Rare Disease and Orphan Drugs Committee
Published: 2023-09-07 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.22%
rare disease
The Science Times Publishes Article About Jaguar Health's Focus on Developing Crofelemer for Two Rare Disease Indications
Published: 2023-08-30 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: -2.28%
H: 0.5%
C: -4.94%
rare disease crofelemer
Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference
Published: 2023-08-28 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 0.0%
H: 2.47%
C: 1.25%
conference health global growth
Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
Published: 2023-08-24 (Crawled : 11:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: 0.0%
health
Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
Published: 2023-08-17 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: -4.06%
H: 0.41%
C: -2.97%
diarrhea health cancer treatment family crofelemer trial
Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
Published: 2023-08-16 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 6.57%
H: 0.0%
C: 0.0%
diarrhea indicate world sclerosis treatment pharmaceuticals potential
Jaguar Health Reports Second Quarter 2023 Financial Results
Published: 2023-08-14 (Crawled : 12:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -9.19%
health financial results
Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
Published: 2023-08-10 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 1.29%
H: 8.87%
C: 6.74%
health
Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
Published: 2023-08-09 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 0.85%
H: 0.84%
C: -10.4%
np-300 drug candidate diarrhea health application family funding
Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
Published: 2023-08-08 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
fda drug disease health microvillus treatment application crofelemer
Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea
Published: 2023-08-07 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 1.2%
H: 3.33%
C: 0.63%
diarrhea breast cancer crofelemer study
Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
Published: 2023-08-03 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: -0.75%
H: 0.35%
C: -4.52%
health group wall
REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th
Published: 2023-08-02 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: -1.99%
H: 2.02%
C: 0.06%
health
Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)
Published: 2023-08-01 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 1.02%
H: 0.67%
C: -2.84%
fda drug diarrhea health treatment application crofelemer
In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon
Published: 2023-07-27 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 4.99%
H: 0.0%
C: -7.98%
health world amazon
Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Published: 2023-07-26 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | $0.356 0.62% 0.14% 5.6M
|
Health Technology
|
| O: 2.57%
H: 11.58%
C: 6.27%
diarrhea health approval treatment trial
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K
|
Finance
BKKT 4 | $1.88 25.33% 14.89% 4.8M
|
MGLD | $1.03 7.77% 14K
|
Manufacturing
CZOO | $0.4316 -6.52% 6.7% 65K
|
SATX | $0.4226 -1.72% 6.48% 29K
|
n/a
CCJ | $45.4 -1.13% 4.6% 3.9M
|
Non-Energy Minerals
AUMN | $0.562 0.34% 4.5% 360K
|
Non-Energy Minerals
JBL | $116.91 1.38% 4.3% 2M
|
Electronic Technology
SAIC 4 | $119.92 2.14% 4.24% 460K
|
Technology Services
CULP 4 | $5.06 -0.59% 3.95% 29K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.